Early effects of paroxysmal atrial fibrillation on plasma markers of fibrinolysis

摘要

There are no studies to date on the early changes in the hemostasis profile of patients with paroxysmal atrial fibrillation (PAF). Given the key role of the fibrinolytic system in maintaining blood fluidity, our aim was to examine its activity in patients with clinical manifestation of the disease We studied 51 nonanticoagulated patients with a first episode of the disease (26 men, 25 women; mean age 59.84?±?1.60 years) and 52 controls (26 men, 26 women; mean age 59.50?±?1.46 years) who matched the patients in terms of gender, age, comorbidities, and conducted treatment. Using enzyme-linked immunoassays and colorimetric assays we assessed the plasminogen activity, tissue plasminogen activator level (t-PA), plasminogen activator inhibitor 1 activity (PAI-1), α2-antiplasmin activity (α2-AP), D-dimer level, and vitronectin level. Blood samples were collected immediately after hospitalization. Patients were hospitalized between the second and twenty fourth hours (mean 8.14?±?0.76?hours) after the onset of PAF. Compared to controls, plasminogen (159.40?±?4.81 vs 100.2?±?2.88%, P??0.001) and t-PA levels (11.25?±?0.35 vs 6.05?±?0.31?ng/mL, P??0.001) were significantly higher in the patient group. PAI-1 activity (7.33?±?0.37 vs 15.15?±?0.52?AU/mL, P??0.001) and α2-AP (112.9?±?2.80 vs 125.60?±?3.74%, P??0.05) as well as vitronectin plasma levels (134.7?±?5.83 vs 287.3?±?10.44?mcg/mL, P??0.001) were lower in the PAF group. Conversely, the levels of D-dimer in patients were significantly higher (0.53?±?0.07 vs 0.33?±?0.02?ng/mL, P??0.05). Early changes in the fibrinolytic system occur in PAF, suggesting their close relationship with the manifestation of the disease. There is high plasma fibrinolytic activity, during the very first 24 hours of the disease, which is most likely a pathophysiological response to the intensified procoagulation process.